Literature DB >> 14657605

Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models.

Jose-Luis González De Aguilar1, Frédérique René, Luc Dupuis, Jean-Philippe Loeffler.   

Abstract

The nervous system plays a key role in the regulation of neuroendocrine axes and, in turn, the released neurohormones modulate the activity of different brain regions. Neurodegenerative diseases, which are known to affect specific neuronal populations, may provoke neuroendocrine dysfunctions that alter the intimate relationship between both systems. In addition, these modifications may influence the progression of the neurodegenerative process. In the present review, we summarise some of the endocrine changes characterising three major neurodegenerative diseases: Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Special attention is focused on the contribution of disease transgenic models to elucidate such alterations. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 14657605     DOI: 10.1159/000074445

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  4 in total

1.  Dipeptide repeat protein and TDP-43 pathology along the hypothalamic-pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases.

Authors:  Lieselot Dedeene; Evelien Van Schoor; Simona Ospitalieri; Alicja Ronisz; Jochen H Weishaupt; Markus Otto; Albert C Ludolph; Angelika Scheuerle; Rik Vandenberghe; Philip Van Damme; Koen Poesen; Dietmar Rudolf Thal
Journal:  Acta Neuropathol       Date:  2020-08-30       Impact factor: 17.088

2.  Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease.

Authors:  Jing Lin; Xian Li; Fangping Yuan; Ling Lin; Christine L Cook; Ch V Rao; Zhenmin Lei
Journal:  J Neuropathol Exp Neurol       Date:  2010-03       Impact factor: 3.685

Review 3.  Weight loss in neurodegenerative disorders.

Authors:  N A Aziz; M A van der Marck; H Pijl; M G M Olde Rikkert; B R Bloem; R A C Roos
Journal:  J Neurol       Date:  2009-01-22       Impact factor: 4.849

4.  Neuroendocrine disturbances in Huntington's disease.

Authors:  Nadine Saleh; Stéphane Moutereau; Alexandra Durr; Pierre Krystkowiak; Jean-Philippe Azulay; Christine Tranchant; Emmanuel Broussolle; Françoise Morin; Anne-Catherine Bachoud-Lévi; Patrick Maison
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.